iBio Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About iBio Inc
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
/ 
Frequently asked questions
To buy iBio Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for iBio Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for iBio Inc is IBIO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
iBio Inc has its primary listing on NASDAQ (Small cap). You can trade iBio Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, iBio Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include iBio Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like iBio Inc.